search
Back to results

Optimizing Tobacco Dependence Treatment in the Emergency Department

Primary Purpose

Tobacco Use Disorder

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Brief Negotiated Interview (BNI)
Nicotine replacement therapy (NRT)
CT Smokers Quitline (QL)
SmokefreeText (Text)
Sponsored by
Yale University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tobacco Use Disorder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 18 years or older
  • have smoked >= 100 cigarettes lifetime
  • describe themselves as every or some day smokers
  • smoke at least 5 cigarettes/day
  • own a cellphone with texting capability
  • are able to give written informed consent

Exclusion Criteria:

  • Inability to read or understand English
  • currently receiving formal tobacco dependence treatment
  • life-threatening or unstable medical, surgical, or psychobehavioral condition
  • unable to provide at least one collateral contact
  • live out-of-state
  • leaving the ED against medical advice
  • pregnant (self-report or urine testing), nursing, or trying to conceive.

Sites / Locations

  • Yale School of Medicine

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm 7

Arm 8

Arm 9

Arm 10

Arm 11

Arm 12

Arm 13

Arm 14

Arm 15

Arm 16

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

No Intervention

Arm Label

BNI+NRT+QL+Text

BNI+NRT+QL

BNI+NRT+Text

BNI+NRT

BNI+QL+Text

BNI+QL

BNI+Text

BNI only

NRT+QL+Text

NRT+QL

NRT+Text

NRT only

QL+Text

QL only

Text only

Control

Arm Description

Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text)

Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL)

Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Registration in SmokefreeText (Text)

Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply

Brief Negotiated Interview (BNI) Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text)

Brief Negotiated Interview (BNI) Referral to CT Smokers Quitline (QL)

Brief Negotiated Interview (BNI) Registration in SmokefreeText (Text)

Brief Negotiated Interview (BNI)

Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text)

Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL)

Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Registration in SmokefreeText (Text)

Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply

Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text)

Referral to CT Smokers Quitline (QL)

Registration in SmokefreeText (Text)

Control arm, no intervention

Outcomes

Primary Outcome Measures

Tobacco Abstinence
Abstinence self reported and verified by exhaled carbon monoxide

Secondary Outcome Measures

Full Information

First Posted
September 6, 2016
Last Updated
November 19, 2020
Sponsor
Yale University
Collaborators
National Cancer Institute (NCI), National Institutes of Health (NIH)
search

1. Study Identification

Unique Protocol Identification Number
NCT02896400
Brief Title
Optimizing Tobacco Dependence Treatment in the Emergency Department
Official Title
Optimizing Tobacco Dependence Treatment in the Emergency Department
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
February 13, 2017 (Actual)
Primary Completion Date
August 14, 2019 (Actual)
Study Completion Date
August 14, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yale University
Collaborators
National Cancer Institute (NCI), National Institutes of Health (NIH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators propose an innovative full-factorial design in a cohort of 1056 adult smokers in an urban emergency department (ED), to test the efficacy of four key intervention components: motivational interviewing, medication, quitline referral, and texting. At the trial's completion, a mixed-methods approach will be used to identify the components that were efficacious within the proposed cost constraint, along with feasibility and acceptability to providers and subjects. The investigators will then assemble an intervention that maximizes efficacy, given a cost-effectiveness constraint and findings from a qualitative analysis.
Detailed Description
The investigators propose to optimize the identification and treatment of adult smokers seen in a hospital ED. To do this the Multiple Optimization Strategy (MOST) will be employed to develop a multicomponent intervention that will consist of some combination of the following: (1) a Brief Negotiation Interview (BNI, a variant of a motivational interview), delivered by a trained research assistant; (2) provision of 6 weeks of nicotine patches and gum to the research participant, with application of the first patch in the ED (NRT); (3) active referral to the Connecticut Smokers' Quitline (QL); and (4) enrollment in the SmokefreeText a short-messaging service (SMS) texting program for mobile phones (Text). Using MOST principles, the first phase of the study will use a 2x2x2x2 full-factorial design to identify the components most likely to be efficacious in combination. Although the factorial design requires the allocation of participants to 16 different combinations of the 4 components (Table 1), evaluation of each individual component is performed comparing all of those receiving a component to all of those not receiving a component, making this an efficient design. For instance, evaluation of the BNI component will compare those randomized to arms 1 through 8 to those in arms 9 to 16.The second phase will consist of designing and proposing a 2-arm randomized clinical trial comparing the efficacy of the multicomponent intervention package to usual care; this will be conducted in a future application. The specific aims of this proposed study are: Aim 1. To conduct a fully powered factorial randomized trial of 1056 adult smokers to test the efficacy of 4 key components of ED-initiated tobacco treatment: Brief Negotiated Interview (BNI), nicotine replacement therapy (NRT), Quitline referral (QL), and SmokeFreeText (Text). Aim 2. To identify the most efficacious components of our intervention, within fixed constraints of cost effectiveness and feasibility/acceptability to providers and subjects. Aim 3. To lay the groundwork for a future randomized trial testing the previously identified components, delivered as a package, against a control arm in a new cohort of adult ED smokers. Our associated hypotheses are: At 3 months, at least 1 intervention component will yield a biochemically verified tobacco abstinence rate at least 5% greater than in the control condition. Carbon monoxide breath test will be used for biochemical verification. At 3 months, at least 1 intervention will be cost-effective, using a societal perspective. At 3 months, at least 1 intervention will be acceptable and feasible to providers and subjects.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tobacco Use Disorder

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Factorial Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
1056 (Actual)

8. Arms, Groups, and Interventions

Arm Title
BNI+NRT+QL+Text
Arm Type
Experimental
Arm Description
Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text)
Arm Title
BNI+NRT+QL
Arm Type
Experimental
Arm Description
Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL)
Arm Title
BNI+NRT+Text
Arm Type
Experimental
Arm Description
Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Registration in SmokefreeText (Text)
Arm Title
BNI+NRT
Arm Type
Experimental
Arm Description
Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply
Arm Title
BNI+QL+Text
Arm Type
Experimental
Arm Description
Brief Negotiated Interview (BNI) Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text)
Arm Title
BNI+QL
Arm Type
Experimental
Arm Description
Brief Negotiated Interview (BNI) Referral to CT Smokers Quitline (QL)
Arm Title
BNI+Text
Arm Type
Experimental
Arm Description
Brief Negotiated Interview (BNI) Registration in SmokefreeText (Text)
Arm Title
BNI only
Arm Type
Experimental
Arm Description
Brief Negotiated Interview (BNI)
Arm Title
NRT+QL+Text
Arm Type
Experimental
Arm Description
Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text)
Arm Title
NRT+QL
Arm Type
Experimental
Arm Description
Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL)
Arm Title
NRT+Text
Arm Type
Experimental
Arm Description
Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Registration in SmokefreeText (Text)
Arm Title
NRT only
Arm Type
Experimental
Arm Description
Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply
Arm Title
QL+Text
Arm Type
Experimental
Arm Description
Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text)
Arm Title
QL only
Arm Type
Experimental
Arm Description
Referral to CT Smokers Quitline (QL)
Arm Title
Text only
Arm Type
Experimental
Arm Description
Registration in SmokefreeText (Text)
Arm Title
Control
Arm Type
No Intervention
Arm Description
Control arm, no intervention
Intervention Type
Behavioral
Intervention Name(s)
Brief Negotiated Interview (BNI)
Intervention Description
Brief motivational interview on smoking behavior
Intervention Type
Drug
Intervention Name(s)
Nicotine replacement therapy (NRT)
Intervention Description
6 weeks of nicotine replacement, patches and gum. First dose of each started in ED. Patches are 14mg or 21 mg. Gum is 2mg per piece.
Intervention Type
Other
Intervention Name(s)
CT Smokers Quitline (QL)
Intervention Description
Faxed referral to the CT Smokers Quitline for the subject. QL will then call subject to offer phone based counseling.
Intervention Type
Other
Intervention Name(s)
SmokefreeText (Text)
Intervention Description
Enrollment in a version of NCI's SmokefreeTxt, tailored for the study.
Primary Outcome Measure Information:
Title
Tobacco Abstinence
Description
Abstinence self reported and verified by exhaled carbon monoxide
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years or older have smoked >= 100 cigarettes lifetime describe themselves as every or some day smokers smoke at least 5 cigarettes/day own a cellphone with texting capability are able to give written informed consent Exclusion Criteria: Inability to read or understand English currently receiving formal tobacco dependence treatment life-threatening or unstable medical, surgical, or psychobehavioral condition unable to provide at least one collateral contact live out-of-state leaving the ED against medical advice pregnant (self-report or urine testing), nursing, or trying to conceive.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven L Bernstein, MD
Organizational Affiliation
Yale School of Medicine, Department of Emergency Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Yale School of Medicine
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06519
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
29287665
Citation
Bernstein SL, Dziura J, Weiss J, Miller T, Vickerman KA, Grau LE, Pantalon MV, Abroms L, Collins LM, Toll B. Tobacco dependence treatment in the emergency department: A randomized trial using the Multiphase Optimization Strategy. Contemp Clin Trials. 2018 Mar;66:1-8. doi: 10.1016/j.cct.2017.12.016. Epub 2017 Dec 27.
Results Reference
derived

Learn more about this trial

Optimizing Tobacco Dependence Treatment in the Emergency Department

We'll reach out to this number within 24 hrs